Waters Corp（WAT）股票分析WATWaters Corp

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Waters Corp is a good buy right now due to its strong recent earnings performance, with Q2 revenue of $1.65 billion and adjusted EPS of $3.05, both exceeding expectations. Additionally, the stock has shown a year-to-date change of +18.77%, indicating solid momentum. However, the main risk is the recent decline in net income, with a reported loss of -72 million in Q1 2026 and -136 million in Q2 2026, which could impact future profitability.

15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.